These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20114004)

  • 1. Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review.
    Bigos KL; Pollock BG; Stankevich BA; Bies RR
    Gend Med; 2009 Dec; 6(4):522-43. PubMed ID: 20114004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in the pharmacokinetics and pharmacodynamics of antidepressants.
    Bies RR; Bigos KL; Pollock BG
    J Gend Specif Med; 2003; 6(3):12-20. PubMed ID: 14513571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in pharmacokinetics of antidepressants.
    Kokras N; Dalla C; Papadopoulou-Daifoti Z
    Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):213-26. PubMed ID: 21192772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in depression and antidepressant pharmacokinetics and adverse events.
    Frackiewicz EJ; Sramek JJ; Cutler NR
    Ann Pharmacother; 2000 Jan; 34(1):80-8. PubMed ID: 10669189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antidepressant pharmacokinetics during pregnancy].
    Maslovskiĭ SIu
    Eksp Klin Farmakol; 2013; 76(1):14-20. PubMed ID: 23461010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives.
    Damoiseaux VA; Proost JH; Jiawan VC; Melgert BN
    Clin Pharmacokinet; 2014 Jun; 53(6):509-19. PubMed ID: 24859034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication.
    Yonkers KA; Kando JC; Cole JO; Blumenthal S
    Am J Psychiatry; 1992 May; 149(5):587-95. PubMed ID: 1575248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characterisation of selected molecular mechanisms influencing pharmacokinetics and pharmacodynamics of antidepressants].
    Jeleń A; Sałagacka A; Balcerczak E
    Postepy Hig Med Dosw (Online); 2015 Jul; 69():753-62. PubMed ID: 26206991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacologic treatment of depression: is gender a critical factor?
    Yonkers KA; Brawman-Mintzer O
    J Clin Psychiatry; 2002 Jul; 63(7):610-5. PubMed ID: 12143920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of gender on antidepressants.
    Sramek JJ; Cutler NR
    Curr Top Behav Neurosci; 2011; 8():231-49. PubMed ID: 21374019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic considerations for current state-of-the-art antidepressants.
    Wyska E
    Expert Opin Drug Metab Toxicol; 2019 Oct; 15(10):831-847. PubMed ID: 31526279
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical implications of antidepressant pharmacokinetics and pharmacogenetics.
    Cohen LJ; De Vane CL
    Ann Pharmacother; 1996 Dec; 30(12):1471-80. PubMed ID: 8968460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressants' effects on testosterone and estrogens: What do we know?
    Pavlidi P; Kokras N; Dalla C
    Eur J Pharmacol; 2021 May; 899():173998. PubMed ID: 33676942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition and management of depression in primary care: a focus on the elderly. A pharmacotherapeutic overview of the selection process among the traditional and new antidepressants.
    Barkin RL; Schwer WA; Barkin SJ
    Am J Ther; 2000 May; 7(3):205-26. PubMed ID: 11317169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in depression.
    Sagud M; Hotujac Lj; Mihaljević-Peles A; Jakovljević M
    Coll Antropol; 2002 Jun; 26(1):149-57. PubMed ID: 12137295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressants for depression in physically ill people.
    Rayner L; Price A; Evans A; Valsraj K; Higginson IJ; Hotopf M
    Cochrane Database Syst Rev; 2010 Mar; (3):CD007503. PubMed ID: 20238354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapy for geriatric depression.
    Bressler R; Katz MD
    Drugs Aging; 1993; 3(3):195-219. PubMed ID: 8324296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics of antidepressant drugs.
    Horstmann S; Binder EB
    Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP).
    Nagler EV; Webster AC; Vanholder R; Zoccali C
    Nephrol Dial Transplant; 2012 Oct; 27(10):3736-45. PubMed ID: 22859791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics and personalized medicine in antidepressant treatment.
    Gvozdic K; Brandl EJ; Taylor DL; Müller DJ
    Curr Pharm Des; 2012; 18(36):5853-78. PubMed ID: 22681166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.